Efficacy of osimertinib against EGFRvIII+ glioblastoma. - Chagoya G; Kwatra SG; Nanni CW; Roberts CM; Phillips SM; Nullmeyergh S; Gilmore SP; Spasojevic I; Corcoran DL; Young CC; Ballman KV; Ramakrishna R; et al. (Oncotarget, 2020)